Patents by Inventor Simon MESSNER

Simon MESSNER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240043808
    Abstract: An in vitro testing platform for the study of metabolic liver disease and related therapeutic strategies, composed of an artificial spheroidal microtissue comprising at least hepatocytes and hepatic stellate cells, and at least one type of hepatic inflammatory cells and further medium and reagents capable to establish and simulate different stages of metabolic liver disease and their progression and testing preventive and therapeutic strategies by pharmacological and/or dietary interventions.
    Type: Application
    Filed: August 7, 2023
    Publication date: February 8, 2024
    Inventors: Simon Messner, Jens M Kelm, Radina Kostadinova-Angelova, Wolfgang Moritz
  • Publication number: 20230235277
    Abstract: A 3D tissue culture selected from the group consisting of hydrogel-based 3D tissue culture and cellular self-assembly 3D tissue culture as well as self-assembly 3D tissue culture. Additionally, disclosed is a method of preparing cells for 3D tissue culture, which method comprises the steps of plating the cells on a suitable surface, optionally, checking for their capability to adhere to said surface, discarding the cells which have not adhered to said surface, detaching the adhered cells and transferring them into a 3D tissue culture process.
    Type: Application
    Filed: January 26, 2023
    Publication date: July 27, 2023
    Inventors: Simon Messner, Wolfgang Moritz, Jan Lichtenberg, Jens Kelm
  • Publication number: 20190316093
    Abstract: The present invention relates to an in vitro testing platform for the study of metabolic liver disease and related therapeutic strategies, composed of an artificial spheroidal microtissue comprising at least hepatocytes and hepatic stellate cells, and at least one type of hepatic inflammatory cells and further medium and reagents capable to establish and simulate different stages of metabolic liver disease and their progression and testing preventive and therapeutic strategies by pharmacological and/or dietary interventions.
    Type: Application
    Filed: December 27, 2017
    Publication date: October 17, 2019
    Inventors: Simon Messner, Jens M. Kelm, Radina Kostadinova-Angelova, Wolfgang Moritz
  • Publication number: 20190079079
    Abstract: The present invention relates to a method and/or assay for the assessment of the metabolic effect of a candidate compound. The method and/or assay comprises exposing one or more 3-dimensional cell culture or tissue to one or more candidate compounds, and measuring, in at least one 3-dimensional cell culture or tissue, the effect of such exposure on the 3-dimensional cell culture or tissue-specific respiration rate (MTSRR) (FIG. 1B).
    Type: Application
    Filed: March 14, 2017
    Publication date: March 14, 2019
    Inventors: Jens Kelm, Simon Messner
  • Publication number: 20170037364
    Abstract: The present invention relates to a method of preparing cells for 3D tissue culture, which method comprises the steps of plating the cells on a suitable surface, optionally, checking for their capability to adhere to said surface, discarding the cells which have not adhered to said surface, detaching the adhered cells and transferring them into a 3D tissue culture process.
    Type: Application
    Filed: April 15, 2015
    Publication date: February 9, 2017
    Inventors: Simon MESSNER, Wolfgang MORITZ, Jan LICHTENBERG, Jens M. KELM